James Davitt, MD
Foot and Ankle Surgery · Portland, ORNPI 1255374740
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Stryker at 44.8% of the total. Reporting peaked in 2024 at $1,132 and has fallen 98.3% since, to $20 in 2025.
Across 33 payments — averaging $94.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Paragon 28, Inc.$822
- Exactech, Inc.$358
- Zimmer Biomet$227
- Integra Lifesciences Corporation$137
- Steelhead Surgical Inc$67
- plus $105 from 4 others
Across 25 payments — averaging $1507.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$38K
What the payments were for
- Travel & lodging$1,25840%
- Food & beverage$1,85360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 13 | $1,395 |
| Paragon 28, Inc. | 5 | $822 |
| Exactech, Inc. | 2 | $358 |
| Zimmer Biomet | 2 | $227 |
| Integra Lifesciences Corporation | 5 | $137 |
| Steelhead Surgical Inc | 1 | $67 |
| Johnson & Johnson | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Left Coast Surgical Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$512
- Portfolio$368
- VANTAGE$358
- Additive Orthopedics$338
- INFINITY$326
- AUGMENT INJECTABLE$305
- INBONE$132
- INFINITY ADAPTIS$132
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$125
- CADENCE ANKLE REPLACEMENT SYSTEM$125
- BIOFIX$125
- PANTA NAIL$125
- TOTAL FOOT SYSTEM$125
- Trabecular Metal (TM) Ankle$118
- Affixus$109
How this compares
$3,111 in reported general payments places this provider in the 55th percentile of 113 foot and ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 29 | $130 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $89 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Portland
- Natalie MesnierPortland$339K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Kevin DriscollPortland$21K
- John MassoudPortland$14K
- Kenneth HegewaldPortland$11K
- Steven LaxsonPortland$11K
- Lara AtwaterPortland$10K
- Denny lePortland$9K
- Andrew HuPortland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.